J
Joel Shapiro
Researcher at Erasmus University Rotterdam
Publications - 41
Citations - 3253
Joel Shapiro is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Chemoradiotherapy & Neoadjuvant therapy. The author has an hindex of 22, co-authored 37 publications receiving 2559 citations. Previous affiliations of Joel Shapiro include Rochester General Health System & Utrecht University.
Papers
More filters
Journal ArticleDOI
Autofluorescent Flavoprotein Imaging of Spinal Nociceptive Activity
Joost L M Jongen,Tiziana Pederzani,Sebastiaan K. E. Koekkoek,Joel Shapiro,Johannes van der Burg,Chris I. De Zeeuw,Frank J P M Huygen,Jan C. Holstege +7 more
TL;DR: Using autofluorescent flavoprotein imaging (AFI), an optical technique suitable for mapping activity in nervous tissue, a close temporal and spatial correlation of electrically evoked nociceptive input with the spinal AFI signal is demonstrated, representing spinal neuronal activity.
Journal ArticleDOI
Diffuse pulmonary arteriovenous malformations (angiodysplasia) with unusual histologic features: case report and review of the literature.
Journal ArticleDOI
P53 and SOX2 Protein Expression Predicts Esophageal Adenocarcinoma in Response to Neoadjuvant Chemoradiotherapy.
Sophie H. van Olphen,Katharina Biermann,Joel Shapiro,Bas P. L. Wijnhoven,Eelke L A Toxopeus,Ate van der Gaast,Hans Stoop,J. Jan B. van Lanschot,Manon C.W. Spaander,Marco J. Bruno,Leendert H. J. Looijenga +10 more
TL;DR: Pattern of p53 and particularly SOX2 protein expression in EAC predicts response to nCRT, and these biomarkers may help to individualize treatment in Eac patients.
Journal ArticleDOI
Upper Gastrointestinal Bleeding due to Metastatic Endometrial Adenocarcinoma.
TL;DR: This work presents a rare case of UGIB due to endometrial adenocarcinoma metastatic to the third part of the duodenum, a life-threatening complication and a commonly encountered diagnosis requiring hospitalization.
Journal ArticleDOI
Reply to Letter: "Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa".
TL;DR: It is suggested that post-nCRT bite-on-bite biopsies or fineneedle aspirations would improve the sensitivity of identifying noncomplete responders and be interpreted with caution in patients with residual tumor in the submucosa.